US Stocks
/
Alaunos Therapeutics, Inc. Share Price

Alaunos Therapeutics, Inc. Share Price

NASDAQ: TCRT | Micro Cap
$1.57
-$0.14 (-8.19%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alaunos Therapeutics, Inc. Stock Performance

Open
$1.61
Prev. Close
$1.71
Circuit Range
N/A
Day Range
$1.56 - $1.71
Year Range
$1.56 - $4.58
Volume
2,065
Average Traded
$1.62

Alaunos Therapeutics, Inc. Share Price Today

As of 30 August 2026, Alaunos Therapeutics, Inc.'s share price is $1.57. The stock opened at $1.61, compared to its previous close of $1.71. During today's trading session, Alaunos Therapeutics, Inc.'s share price traded between $1.56 and $1.71, with an average price of $1.64. Over the past 52 weeks, the stock has recorded a high of $4.58 and a low of $1.56. In terms of performance, Alaunos Therapeutics, Inc.'s share price has declined by 50.16% over the last six months and is down 23.79% on a year-on-year basis.

Alaunos Therapeutics, Inc. Share Price Chart

$1.56$1.71
L
Show Current Price
H

Alaunos Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.06M
PE Ratio (TTM)
-0.71
Dividend Yield
N/A
EPS (TTM)
$-2.20
Revenue (TTM)
$5000.00
Return On Equity (TTM)
-193.96%
Profit Margin
-83520.00%
Debt to Equity
0.38
Quarterly Earnings Growth YoY
-2.84%

Alaunos Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$1000.00$4000.00$0.00$2000.00$0.00$0.00
Net Profit-$1.68M-$1.13M-$1.13M-$1.07M-$1.05M-$1.16M
Net Profit Margin-168200.00%-28225.00%N/A-53650.00%N/AN/A
Income ChangeN/A32.88%0.18%4.79%2.05%-10.28%

Alaunos Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232025
Revenue$2.92M$5000.00$5000.00
Net Profit-$37.73M-$35.14M-$4.18M
Net Profit Margin-1291.24%-702800.00%-83520.00%
Income ChangeN/A6.86%88.12%

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Alaunos Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.91
$1.71
-8.56%
Jul 2026
$2.27
$1.87
-19.05%
Jun 2026
$2.83
$2.31
-21.43%
May 2026
$2.88
$2.94
+17.60%
Apr 2026
$3.05
$2.50
-14.68%
Mar 2026
$3.32
$2.93
-6.98%
Feb 2026
$2.66
$3.15
+7.14%
Jan 2026
$3.25
$2.94
-9.54%
Dec 2025
$3.17
$3.25
-0.61%
Nov 2025
$2.62
$3.27
+18.05%
Oct 2025
$2.48
$2.77
+12.60%
Sep 2025
$2.16
$2.46
+19.42%

TCRT Share Price FAQs

What is Alaunos Therapeutics, Inc. share price today?

chevron-up
Alaunos Therapeutics, Inc. share price today is $1.57 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Alaunos Therapeutics, Inc. stock?

chevron-up
The 52 week high of Alaunos Therapeutics, Inc. stock is $4.58, while the 52 week low is $1.56 as of 29 Aug '26.

What is TCRT's market capitalisation today?

chevron-up
TCRT market capitalisation is $3.06M as of August 30, 2026, at 10:18 am IST.

What is TCRT's net income for the last quarter?

chevron-up
TCRT's net income for the last quarter is -0.00B USD.

What is the 5 year returns of TCRT?

chevron-up
The 5 year returns of TCRT is -99.36% as on 29 Aug '26.

What is the high & low stock price of TCRT today?

chevron-up
TCRT stock price hit a high of $1.71 and low of $1.56 as of 29 Aug '26.

Can I buy TCRT shares in India?

chevron-up
Yes. You can buy TCRT in India by opening an international trading account.